Anthropic · 2026-07-20 · major
Anthropic Rare Disease Grants — $50K in Claude credits for rare-genetic-disease research
Anthropic's AI for Science program is accepting applications until August 2 for up to $50,000 in Claude credits per team, over six months, on rare genetic disease research across a Basic Science and a Biotech track.
Anthropic opens a rare-disease research track: up to $50K in Claude credits per team, apply by August 2.
Quick facts
| Program | AI for Science — rare disease research grants |
|---|---|
| Maker | Anthropic |
| Award | Up to $50,000 in Claude credits per team, 6 months |
| Tracks | Basic Science, Biotech |
| Application deadline | August 2, 2026, 11:59 PM PST |
| Models | Claude Opus and other approved models |
| Extras | Access to the Claude Science workbench |
What is it?
The Anthropic rare disease grants are a focused call under the AI for Science program that funds researchers working on rare genetic diseases with up to $50,000 in Claude API credits per team over six months, split into a Basic Science track and a Biotech track.
How does it work?
Applicants pick one of two tracks — Basic Science (clinicians, patient orgs, data scientists studying disease mechanisms; results shared through the Monarch Initiative) or Biotech (early-stage biotechs working on drug development) — and submit a Google form. Accepted teams get Claude credits, access to the Claude Science workbench, and can request exemptions from biosafety classifiers where needed.
Why does it matter?
Rare-disease research is starved of large patient datasets and struggles to find drug targets, so the field has been a natural fit for AI but a bad fit for standard grant math. Direct Claude credits let small clinical teams and early biotechs run compute-heavy analyses they otherwise could not afford, and the Monarch-Initiative-sharing rule means outputs feed a shared public knowledge base rather than sitting inside one lab.
Who is it for?
clinical researchers, patient-advocacy data scientists, early-stage rare-disease biotechs
Frequently asked questions
- How much does the Anthropic rare disease grant award?
- The AI for Science rare disease grant awards up to $50,000 in Claude API credits per accepted team, usable over six months. It is credit — not cash — and covers Claude Opus plus other approved models, along with access to the Claude Science research workbench.
- Who can apply for the Anthropic rare disease grant?
- Two tracks are open. The Basic Science track wants partnerships between clinical researchers, patient organizations, and data scientists studying rare-disease mechanisms, with results shared publicly through the Monarch Initiative. The Biotech track wants early-stage biotechs and biotechnologists accelerating drug development for rare diseases.
- When does the Anthropic rare disease grant application close?
- Applications close on August 2, 2026 at 11:59 PM PST. Anthropic points teams to a Google Form linked from the announcement page, and says future community-building efforts, including hackathons, will follow the first grant cycle.
- Can Anthropic rare disease grantees use Claude for biology work that biosafety filters block?
- Yes. Anthropic says projects that may conflict with Claude's biosafety classifiers can request an exemption as part of their application, so rare-disease work involving sensitive biology is not automatically ruled out — grantees just have to flag the need and get it approved.
Try it
https://www.anthropic.com/news/rare-disease-research-grants